November 21st 2022
Tell your patients to get their annual flu vaccines for best protection against illness.
October 24th 2022
CDC, other experts are tracking increases in respiratory syncytial virus cases in infants.
February 1st 2022
A new poll suggests that misconceptions about the flu vaccine are at a three-year high, despite the fact that more patients seem to be receiving the vaccine. Find out what physicians can do to clear the air.
Fewer than half of American adults receive vaccinations for influenza and pneumonia.
December 6th 2021
National Influenza Vaccination Week is Dec. 5-11
Flu season less severe than last
H1N1 is the most prevalent flu virus circulating this year, resulting in a less severe flu season overall than last year when H3N2 was predominant.
Early oseltamivir treatment associated with 30 percent decrease in mortality for some flu strains
A new report links early treatment of influenza A/H3N2 with the drug to a 30% decrease in mortality.
Could a probiotic help prevent the flu?
Researchers have found that the microbiome in the respiratory tract contributes to how susceptible we each are to the flu. Work is underway to use this data to create a preventive tool
Llama antibodies may hold key to broad-coverage flu vaccine
A new study reveals that llama antibodies may be effective in offering protection against numerous flu strains in a single vaccine
Flu vaccination rates decline as clinic days wear on
A new report highlights how flu vaccination rates decline as the day progresses, and how primary care practices can use ‘nudges’ to modify patient care behaviors.
New nanoparticle flu vaccine could benefit senior patients
A new vaccine in development could provide increased flu protection for seniors.
Early activity indicates this year’s flu vaccine may be a good match
It’s too early yet to say whether last year’s devastating flu season will motivate more patients to receive flu shots, but so far it looks like a good year for the vaccine.
The promise of a new intranasal flu vaccine: Better protection, less side effects
NasoVax is still in the development stages but may eventually provide an option for patients who are immunocompromised.
New antiviral approved just in time for flu season
A new one-dose antiviral-the first treatment approved to fight the flu in 20 years-will be available to clinicians this flu season.
CDC releases updated recommendations for flu season
The intranasal vaccine is back, and changes have been made to the viral composition of this year’s vaccine.
2 Clarke Drive Cranbury, NJ 08512